Expired
Lead Plaintiff Deadline
Oct 14, 2025
Choose your preferred way to stay informed of new case launches and settlement deadlines
The filed complaint alleges that Unicycive Therapeutics, Inc. made materially false and/or misleading statements and/or failed to disclose that: (i) Unicycive’s readiness and ability to satisfy the FDA’s manufacturing compliance requirements was overstated; (ii) the oxylanthanum carbonate new drug application’s regulatory prospects were likewise overstated; and (iii) as a result, defendants’ public statements were materially false and misleading at all relevant times.
In order to be eligible to join the UNCY class action lawsuit, you must have incurred a loss on shares of Unicycive Therapeutics, Inc. purchased during the class period listed above.
If you suffered a loss in Unicycive Therapeutics, Inc. during the relevant time frame or pursuant to the relevant offering(s), you have until October 14, 2025 to request that the Court appoint you as lead plaintiff. Your ability to share in any recovery doesn't require that you serve as a lead plaintiff.
TOP
